Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Momenta Pharmaceuticals Inc (NASDAQ:MNTA)

13.95
Delayed Data
As of 3:57pm ET
 +0.10 / +0.72%
Today’s Change
8.82
Today|||52-Week Range
19.90
-7.31%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Venkataraman Ganesh Kaundinya
Senior Vice President-Research
Buy1/09/201715,000$12.81$192.2K-14.77%
Venkataraman Ganesh Kaundinya
Senior Vice President-Research
Buy1/09/201724,647$7.41$182.6K-14.77%
Wheeler Craig A
President
Sale2/10/20177,088$18.85$133.6K-26.72%
Shea Richard P
Chief Financial Officer & Senior Vice President
Sale12/15/20167,733$15.00$116.0K-7.67%
Leicher Bruce A
General Counsel & Senior Vice President
Sale1/31/20175,000$18.00$90.0K-26.72%
Shapiro Bennett M
Director
Sale6/01/20165,200$13.00$67.6K+15.51%
Shapiro Bennett M
Director
Buy6/01/20165,200$12.90$67.1K+15.51%
Venkataraman Ganesh Kaundinya
Senior Vice President-Research
Sale2/10/20171,756$18.90$33.2K-26.72%
Shea Richard P
Chief Financial Officer & Senior Vice President
Sale12/15/20162,066$15.00$31.0K-7.67%
Leicher Bruce A
General Counsel & Senior Vice President
Sale2/10/20171,620$18.90$30.6K-26.72%
Page of 8